Terms: = Colorectal cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Treatment
10 results:
1. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
2. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Ultrasound-Guided Stellate Ganglion Block on Postoperative Quality of Recovery in Patients Undergoing Breast cancer Surgery: A Randomized Controlled Clinical Trial.
Yang X; Wu Q; Wang H; Zhang Y; Peng X; Chen L
J Healthc Eng; 2022; 2022():7628183. PubMed ID: 36046011
[TBL] [Abstract] [Full Text] [Related]
4. [Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules].
Gebauer A; Barlag H; Wesselmann S; Biedenweg L; Weitmann K; Klinkhammer-Schalke M; Hoffmann W
Gesundheitswesen; 2020 Sep; 82(8-09):710-715. PubMed ID: 31842241
[TBL] [Abstract] [Full Text] [Related]
5. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Joharatnam-Hogan N; Cafferty F; Hubner R; Swinson D; Sothi S; Gupta K; Falk S; Patel K; Warner N; Kunene V; Rowley S; Khabra K; Underwood T; Jankowski J; Bridgewater J; Crossley A; Henson V; Berkman L; Gilbert D; Kynaston H; Ring A; Cameron D; Din F; Graham J; Iveson T; Adams R; Thomas A; Wilson R; Pramesh CS; Langley R;
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):854-862. PubMed ID: 31477558
[TBL] [Abstract] [Full Text] [Related]
6. [Risk Prediction Using Routine Data: Development and Validation of Multivariable Models Predicting 30- and 90-day Mortality after Surgical treatment of colorectal cancer].
Crispin A; Strahwald B; Cheney C; Mansmann U
Gesundheitswesen; 2018 Nov; 80(11):963-973. PubMed ID: 29864770
[TBL] [Abstract] [Full Text] [Related]
7. Cronkhite-Canada syndrome associated with colon cancer metastatic to liver: A case report.
Wang J; Zhao L; Ma N; Che J; Li H; Cao B
Medicine (Baltimore); 2017 Sep; 96(38):e7466. PubMed ID: 28930817
[TBL] [Abstract] [Full Text] [Related]
8. Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care.
Schimanski CC; Staib F; Göhler T; Hebart H; Heike M; Neise M; Rudi J; Geer T; Dingeldein G; Lang C; Ehscheidt P; Flohr T; Josten KM; Karthaus M; Schmittel A; Wierecky J; Boller E; Indorf M; Wörns MA; Galle PR; Moehler M
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1023-1034. PubMed ID: 28197787
[TBL] [Abstract] [Full Text] [Related]
9. First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis.
Pietrantonio F; Cremolini C; Petrelli F; Di Bartolomeo M; Loupakis F; Maggi C; Antoniotti C; de Braud F; Falcone A; Iacovelli R
Crit Rev Oncol Hematol; 2015 Oct; 96(1):156-66. PubMed ID: 26088456
[TBL] [Abstract] [Full Text] [Related]
10. Current status and future perspectives of endoscopic submucosal dissection for colorectal tumors.
Tanaka S; Terasaki M; Kanao H; Oka S; Chayama K
Dig Endosc; 2012 May; 24 Suppl 1():73-9. PubMed ID: 22533757
[TBL] [Abstract] [Full Text] [Related]
